I know the old term holders endured years of price ranging. this year is slightly different as in all major milestone hurdle has been ticked. I know USA fda is still pending .. but I have a slight feeling it will be approved in AUSTRALIA and Hk. as it's already approved for sales in UK and NZ and HK and AUS will follow suit. just speculating please dont kick me for saying this.
the imminent sales in UK and Europe which is a bigger market than USA is what will excite new investors and Sophs and institution. speculating again.
I came to party just recently and entered at higher sp that most old timers and I m just bullish about this company. I will be honest I m a fundamental investor, fundamentals of this company is sound and the product they have has the potential to treat other forms of cancer. yes there may be delays I don't know how many years, but that is in the past which I didn't endure.
enough of what I think. it doesn't matter. every punter should do their own research and make an informed decision.
cheer mate and have a good weekend.
GLTAH and DYOR and all imo
OSL Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)